Dr. Kelsey Martin, dean of the David Geffen School of Medicine at UCLA, co-chaired a state advisory committee that has issued recommendations on how to improve the health of Californians through precision medicine. Precision medicine uses genetic, environmental and other data to develop personalized diagnostics and treatments; Martin’s role on the committee reflects UCLA Health’s broader commitment to the field, including through the Institute for Precision Health at UCLA.

“To bring the many benefits of precision health to patients will require strong partnerships to support innovation in health care and medicine,” Martin said. “This collaboration — within institutions, across institutions, between care givers and patients, between public and private institutions, and across communities — will help ensure that California leads the way in driving transformative change in health care to improve quality of life globally.”

The committee’s report includes policy and legislative recommendations in five areas: data security and data sharing, patient partnerships, education and workforce development, regulatory issues, and health economics. Among its top recommendations is building secure data platforms for research. During the past few years, UCLA has been instrumental in developing the UC Health Data Warehouse, a large-scale repository for clinical data from electronic health records from the University of California’s five academic medical centers.